Key Opinion Glycaemic control and weight reduction in type 2 diabetes with weekly tirzepatide, a novel GIP/GLP-1 agonist (dummy 38)
Key Opinion Glycaemic control and weight reduction in type 2 diabetes with weekly tirzepatide, a novel GIP/GLP-1 agonist
